One of the major challenges in stem cell transplants is how to obtain sufficient numbers of these remarkably rare cells to put into patients. To help overcome this issue, research from the Centenary Institute, Royal Prince Alfred Hospital and the University of Sydney has found a way to increase the number of blood-forming stem cells when growing them outside of the body.
By using a unique stretchy surface that allows the cells to pull on it, the researchers found they could generate up to three times more stem cells than using current methods alone. Published today in the leading biotechnology journal Nature Biotechnology, lead author Professor John Rasko from the Centenary Institute and RPA Hospital announced these findings could significantly improve the outcomes of stem cell transplants.
Centenary Institute Head of Gene and Stem Cell Therapy Professor John Rasko* said: "Haemopoietic stem cells (HSCs) or blood-forming stem cells play a critical role in creating the blood cells in our body. In order to expand the number of these cells, researchers have attempted to reproduce the unique environment where stem cells live inside the body. In the past we have learnt how to use hormones and drugs to influence these niche environments but less is known about the effect of physical forces.
"Our research has, for the first time, successfully demonstrated that physical forces created by elasticity play a key role in blood-forming cell growth and may mimic the environment of stem cells inside our body. What we've discovered is that blood-forming stem cells like it to be super stretchy because, like a cat on a sofa, they like to pull on their environment."
Dr Jeff Holst#, first author of the publication, combined routinely-used cell hormones with a new elastic-like substance called tropoelastin to coat the plates on which the cells were grown. The study found that growing the stem cells on tropoelastin alone could create as many stem cells as the current hormone-based methods. But the combination of the two produced a super effect with the researchers finding they could create two or three times the number of stem cells than using standard methods on their own.
Professor Tony Weiss^ is a co-author of the Nature Biotechnology paper, and Professor of Biochemistry and Molecular Biotechnology at the University of Sydney. Professor Weiss said: "This is a superb, world class demonstration of leading Australian science. Our inventions are now giving us precise replicas of extraordinarily versatile, natural elastic proteins. By combining our research skills, we have developed a truly impressive technology that we hope will eventually be used to improve the way bone marrow is managed for better medical outcomes."
These findings could be good news for people who receive life-saving stem cell transplants (bone marrow and cord blood transplants) to treat diseased, damaged or faulty stem cells caused by various conditions or treatments such as leukaemia or chemotherapy.
Professor Rasko explained: "By increasing the number of stem cells we can grow outside of the body we could effectively use less bone marrow or cord blood to get the same result or use the same amount to get a much better result. For example, the small quantity of blood used from a cord blood donation often makes it suitable for small children only. Two cord blood donations are usually required to achieve safe transplants in older children or adults. However, in the future, we could use the blood from just one umbilical cord and then increase the number of stem cells to a viable level outside of the body before transplanting these life-saving cells into patients."
For more information on this research or the Centenary Institute visit www.centenary.org.au
*Professor John Rasko is Head of Gene and Stem Cell Therapy at the Centenary Institute. Professor Rasko is also Head, Cell and Molecular Therapies, Royal Prince Alfred Hospital and Professor, Sydney Medical School, University of Sydney.
#Dr Jeff Holst is Head of the Origins of Cancer Laboratory at the Centenary Institute, and is a research fellow at the University of Sydney.
^Professor Tony Weiss is Professor of Biochemistry and Molecular Biotechnology at the University of Sydney. Professor Weiss is also Head of Proteomics and Biotechnology, Molecular Bioscience, University of Sydney.For the full paper or interviews, please contact Tanya Sarina, Communications Manager, Centenary Institute on:
Tanya Sarina | EurekAlert!
Further reports about: > Biochemistry > Biotechnology > Cell Therapy > Head Medium Display > Molecular Target > Nature Biotechnology > Nature Immunology > Stem cell innovation > blood cell > blood-forming stem cells > bone marrow > cell death > cell transplants > cord blood > elasticity > medical research > stem cells
Rochester scientists discover gene controlling genetic recombination rates
23.04.2018 | University of Rochester
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
23.04.2018 | Physics and Astronomy
23.04.2018 | Physics and Astronomy
23.04.2018 | Trade Fair News